Podcast Episodes

Back to Search
Novo Nordisk 2025 Annual Performance and 2026 Strategic Outlook
Novo Nordisk 2025 Annual Performance and 2026 Strategic Outlook

In 2025, Novo Nordisk achieved 10% sales growth, reaching DKK 309 billion, primarily driven by a 31% surge in obesity care. Key developments include …

5 months, 4 weeks ago

Short Long
View Episode
Chubb Limited Q4 2025 Financial Results and Strategic Review
Chubb Limited Q4 2025 Financial Results and Strategic Review

Chubb reported record earnings for Q4 2025, with core operating income rising to $2.98 billion. Strong underwriting performance led to a record low c…

5 months, 4 weeks ago

Short Long
View Episode
Daily Market Recap (February 3rd 2026)
Daily Market Recap (February 3rd 2026)

Markets reacted as the U.S. government reopened and the S&P 500 fell 1%. Disney named Josh D’Amaro CEO, while Tulsi Gabbard faces scrutiny over a Geo…

6 months ago

Short Long
View Episode
Grainger Q4 2025 Performance and Strategic Digital Flywheel Report
Grainger Q4 2025 Performance and Strategic Digital Flywheel Report

Grainger reported 2025 sales of $17.9 billion, navigating inflation and U.K. market exits. While High-Touch Solutions faced margin pressure, Endless …

6 months ago

Short Long
View Episode
Marathon Petroleum Q4 2025 Financial Performance and 2026 Strategic Outlook
Marathon Petroleum Q4 2025 Financial Performance and 2026 Strategic Outlook

Marathon Petroleum reported a strong Q4 2025, with an adjusted EPS of $4.07, beating estimates. High refining utilization (95%) and capture rates dro…

6 months ago

Short Long
View Episode
Eaton Q4 2025 Earnings: Data Center Surge and Strategic Pivot
Eaton Q4 2025 Earnings: Data Center Surge and Strategic Pivot

Eaton reported record Q4 2025 results with $7.06B revenue and $3.33 adjusted EPS. Demand is surging, led by data center orders (up ~200%). To focus o…

6 months ago

Short Long
View Episode
Pfizer Q4 2025 Earnings: Obesity Pipeline and Financial Performance
Pfizer Q4 2025 Earnings: Obesity Pipeline and Financial Performance

Pfizer’s 2026 strategy focuses on Oncology, Obesity, and R&D milestones. Key priorities include advancing ADCs, monthly GLP-1 candidates, and achievi…

6 months ago

Short Long
View Episode
Merck & Co. Q4 2025 Earnings and Strategic Outlook
Merck & Co. Q4 2025 Earnings and Strategic Outlook

Merck’s Q4 2025 results highlight the strategic acquisition of Cidara Therapeutics and the clinical success of Winrevair in PAH. Despite a Gardasil s…

6 months ago

Short Long
View Episode
Pentair Q4 2025 Earnings Report and 2026 Financial Guidance
Pentair Q4 2025 Earnings Report and 2026 Financial Guidance

Pentair’s FY2025 results show record performance, with sales up 2% and adjusted operating income rising 10%. Growth was driven by transformation init…

6 months ago

Short Long
View Episode
ADM Q4 2025 Earnings Report and 2026 Financial Outlook
ADM Q4 2025 Earnings Report and 2026 Financial Outlook

ADM navigated market volatility and resolved regulatory investigations in 2025. Despite lower segment profits from biofuel policy shifts and trade tu…

6 months ago

Short Long
View Episode

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us